Part 7/13:
Research during COVID-19 faces unique obstacles. Laboratory personnel adhere to enhanced biosafety protocols, donning powered air-purifying respirators and working within high-containment facilities to prevent exposure to the live virus. Supply chain disruptions have led to shortages of essential materials like pipette tips and reagents, complicating experiments and delaying progress.
Travel restrictions have also hindered the shipment of critical biological samples and reagents, further stressing the collaborative efforts that underpin vaccine development.